BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6110709)

  • 1. Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor.
    Kranz H; Caddy DJ; Williams AM; Gay W
    J Neurol Neurosurg Psychiatry; 1980 Jun; 43(6):483-8. PubMed ID: 6110709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in myasthenia gravis: electrophysiological studies.
    Campbell WW; Leshner RT; Swift TR
    Ann Neurol; 1980 Dec; 8(6):584-9. PubMed ID: 6260011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenic syndrome studied with single fiber electromyography.
    Schwartz MS; Stålberg E
    Arch Neurol; 1975 Dec; 32(12):815-7. PubMed ID: 173269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exchange plasmapheresis in the combined treatment of generalized myasthenia patients].
    Sazonov AM; Lipats AA; Kil'diushevskiĭ AV; Ol'shanskiĭ AIa; Guseva LL
    Sov Med; 1984; (5):51-4. PubMed ID: 6087471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of neuromuscular transmission].
    Kwieciński H
    Neurol Neurochir Pol; 1998; 32 Suppl 1():13-21. PubMed ID: 9608549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromuscular transmission in patients with myasthenia gravis treated by plasmapheresis and hemosorption].
    Marshaniia ZS; Sanadze AG; Kil'diushevskiĭ AV; Startsev AI
    Klin Med (Mosk); 1987 Jul; 65(7):107-10. PubMed ID: 2822998
    [No Abstract]   [Full Text] [Related]  

  • 10. Motor neuropathy associated with a facilitating myasthenic syndrome.
    Subramony SH; Mitsumoto H; Mishra SK
    Muscle Nerve; 1986 Jan; 9(1):64-8. PubMed ID: 3005856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient.
    Taphoorn MJ; Van Duijn H; Wolters EC
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):880-2. PubMed ID: 2841430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular transmission in myasthenic single motor units.
    Kadrie HA; Brown WF
    J Neurol Neurosurg Psychiatry; 1978 Mar; 41(3):205-14. PubMed ID: 204747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantal components of end-plate potentials in the myasthenic syndrome.
    Lambert EH; Elmqvist D
    Ann N Y Acad Sci; 1971 Sep; 183():183-99. PubMed ID: 4330759
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Miralles F
    Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of decremental response in decentralized muscles of a myasthenic patient.
    Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
    Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review.
    Alboini PE; Damato V; Iorio R; Luigetti M; Evoli A
    Neuromuscul Disord; 2015 Aug; 25(8):646-50. PubMed ID: 26028274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis.
    Kim YI; Sanders DB
    Exp Neurol; 1981 Jul; 73(1):1-19. PubMed ID: 6265267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.